消毒尼古丁剂使听力皮层中与耳相关的抑制功能障碍正常化,并改善耳的行为证据
Madan Ghimire1, Rui Cai1, Lynne Ling1
1Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, United States.
Frontiers in neuroscience
|June 12, 2023
概括
新的研究表明,部分脱敏尼古丁乙胆受体 (nAChR) 激动剂,sazetidine-A和瓦雷尼克林,在大鼠模型中显著降低了耳症状. 这些发现表明,对人类耳治疗有潜在的治疗益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 审计系统研究 审计系统研究
背景情况:
- 耳影响10-20%的人口,没有普遍接受的治疗方法.
- 严重受耳影响的个体中,注意力缺陷很常见.
- 尼古丁乙胆受体 (nAChR) 功能与耳病理生理学有关.
研究的目的:
- 为了研究听力皮层神经元中nAChR功能中与耳相关的改变.
- 评估萨塞蒂丁-A和瓦雷尼克林作为 tinnitus 的潜在治疗药物.
- 探索nAChR变化在与耳相关的注意力缺陷中的作用.
主要方法:
- 使用了一种噪音暴露小鼠模型的耳声.
- 在听觉皮层第5层金字塔 (PNs) 和血管活性肠 (VIP) 神经元上进行了全细胞补丁记录.
- 在行为性耳测试之前,通过皮下注射给药sazetidine-A和varenicline.
主要成果:
- 耳与PNS中nAChR引起的电流减少和VIP神经元中兴奋度增加有关.
- 沙西提丁A和瓦雷尼克林使与耳相关的GABAergic输入电流正常化到PNS.
- 这两种药物都显著减少了声的行为证据,以剂量依赖的方式.
结论:
- 部分无敏化nAChR激活剂显示出对耳的治疗潜力.
- 准nAChR功能可能会缓解与耳相关的注意力障碍.
- 需要进一步临床研究sazetidine-A和瓦雷尼克林用于耳治疗.
相关概念视频
Desensitization and Tachyphylaxis
1.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.9K
CNS Depressants: Alcohol and Nicotine
287
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
287


